ArticleBMC ophthalmology2026
Laser peripheral iridotomy for treating recurrent uveitis-glaucoma-hyphema plus syndrome with a scleral fixed intraocular lens: a case report.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe purpose of this study was to provide a case report of a patient with uveitis-glaucoma-hyphema-vitreous hemorrhage (UGH plus) syndrome with intraocular lens (IOL) scleral fixation who presented with recurrent decreased vision and to discuss potential risk factors and treatment options. CASE PRESENTATION: A 54-year-old man with a history of multiple ocular traumas and surgeries underwent IOL reposition surgery (scleral fixation) in his right eye in July 2020. He complained of having blurred vision after rubbing his right eye in February 2023. We diagnosed him with UGH plus syndrome on the basis of successive anterior chamber inflammation, elevated intraocular pressure (IOP), hyphema and vitreous hemorrhage. Ultrasound biomicroscopy revealed a concave iris. Laser peripheral iridotomy (LPI) effectively controls UGH plus syndrome.
conclusionsWe reported the successful management of UGH plus syndrome with a scleral-fixed IOL via the LPI. Given the increasing prevalence of IOL implantation, great importance should be attached to the possibility of UGH syndrome, especially in patients with high-risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.